Connecting you to content on EBSCOhost

Works matching IS 10685308 AND DT 2023 AND VI 34 AND IP 4

Results: 14

1

Your Medication Information.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 9, doi. 10.1002/pu.31006
Publication type:: Article

2

Approval: Cariprazine.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 8, doi. 10.1002/pu.31005
Publication type:: Article

3

Approval: Lecanemab.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 8, doi. 10.1002/pu.31004
Publication type:: Article

4

Study suggests little risk of childhood ADHD from benzodiazepine exposure.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 8, doi. 10.1002/pu.31003
Publication type:: Article

5

Phase 1b trial of emraclidine for schizophrenia shows minimal adverse events.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 7, doi. 10.1002/pu.31002
Publication type:: Article

6

Risk of poor neonatal adaptation syndrome similar with exposure to antipsychotics, antidepressants.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 7, doi. 10.1002/pu.31001
Publication type:: Article

7

Few cases of serotonin syndrome in patients receiving linezolid and antidepressants.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 7, doi. 10.1002/pu.31000
Publication type:: Article

8

Several diagnoses exacerbate young adult risk of stimulant misuse.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 7, doi. 10.1002/pu.30999
Publication type:: Article

9

Polypharmacy linked to depression relapse in patients with type 2 diabetes.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 6, doi. 10.1002/pu.30998
Publication type:: Article

10

Lecanemab slowed cognitive decline in patients with early Alzheimer's disease.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 4, doi. 10.1002/pu.30997
Publication type:: Article

11

Buprenorphine shows lower risk of adverse neonatal outcomes than methadone.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 3, doi. 10.1002/pu.30996
Publication type:: Article

12

Risperidone dosing schedule.

Published in:

Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 2, doi. 10.1002/pu.30995

By:

Lam, Y. W. Francis

Publication type:

Article

13

Little evidence of malformation risk in antipsychotic‐exposed children.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 1, doi. 10.1002/pu.30994
Publication type:: Article

14

Haloperidol has mixed effects in ICU patients with delirium.

Published in:: Brown University Psychopharmacology Update, 2023, v. 34, n. 4, p. 1, doi. 10.1002/pu.30993
Publication type:: Article